Greenman William Mariner
President and CEO at CERS; Director at CHINOOK THERAPEUTICS, INC.
- Sold, on record
- $6.5M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Jun 30, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- CERSCERUS CORPPresident and CEO
- CHINOOK THERAPEUTICS, INC.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CERS1.9M shares
- CHINOOK THERAPEUTICS, INC.4,155 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CHINOOK THERAPEUTICS, INC.No planMay 30, 2023 2023
Sold 1,155 shares at $23.30 ($27k)
Greenman William Mariner, Director
No 10b5-1 planSold 4.7% of holdings ($578k position)23,643 shares leftFirst sale on recordFiling
- 2 Form 4 sale CERSNo planMar 14, 2024 +289 days
Sold 125,926 shares at $2.04 ($257k)
Greenman William Mariner, President and CEO
No 10b5-1 planSold 3.8% of holdings ($6.7M position)3.2M shares leftFiling
- 3 Form 4 sale CERSRoutineMar 4, 2025 +355 days
Sold 23,023 shares at $1.55 ($36k)
Greenman William Mariner, President and CEO
10b5-1 planSold 0.7% of holdings ($5M position)3.2M shares leftFiling
- 4 Form 4 sale CERSRoutineMar 7, 2025 +3 days
Sold 60,984 shares at $1.50 ($91k)
Greenman William Mariner, President and CEO
10b5-1 planSold 1.4% of holdings ($6.6M position)4.3M shares left1x usual sizeFiling
- 5 Form 4 sale CERSUnusualMar 14, 2025 +7 days
Sold 193,913 shares at $1.45 ($281k)
Greenman William Mariner, President and CEO
10b5-1 planSold 4.5% of holdings ($6.2M position)4.1M shares left3.2x usual sizeFiling
- 6 Form 4 sale CERSRoutineMar 6, 2026 +357 days
Sold 78,187 shares at $2.01 ($157k)
Greenman William Mariner, President and CEO
10b5-1 planSold 1.4% of holdings ($11.1M position)5.4M shares left0.8x usual sizeFiling
- 7 Form 4 sale CERSUnusualMar 12, 2026 +6 days
Sold 447,757 shares at $1.66 ($743k)
Greenman William Mariner, President and CEO
10b5-1 planSold 8.2% of holdings ($9M position)5M shares left5.7x usual sizeFiling
- 8 Form 4 sale CERSRoutineJun 30, 2026 +110 days
Sold 101,919 shares at $2.94 ($300k)
Greenman William Mariner, President and CEO
10b5-1 planSold 2% of holdings ($15.2M position)5.1M shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 2, 2026 | CERS | President and CEO | Form 4 sale | 101,919 | $300k | 2.0% | Routine | SEC |
| Mar 12, 2026 | Mar 16, 2026 | CERS | President and CEO | Form 4 sale | 447,757 | $743k | 8.2% | Unusual | SEC |
| Mar 6, 2026 | Mar 9, 2026 | CERS | President and CEO | Form 4 sale | 78,187 | $157k | 1.4% | Routine | SEC |
| Mar 14, 2025 | Mar 17, 2025 | CERS | President and CEO | Form 4 sale | 193,913 | $281k | 4.5% | Unusual | SEC |
| Mar 7, 2025 | Mar 10, 2025 | CERS | President and CEO | Form 4 sale | 60,984 | $91k | 1.4% | Routine | SEC |
| Mar 4, 2025 | Mar 5, 2025 | CERS | President and CEO | Form 4 sale | 23,023 | $36k | 0.7% | Routine | SEC |
| Mar 14, 2024 | Mar 14, 2024 | CERS | President and CEO | Form 4 sale | 125,926 | $257k | 3.8% | No plan | SEC |
| May 30, 2023 | May 31, 2023 | CHINOOK THERAPEUTICS, INC. | Director | Form 4 sale | 1,155 | $27k | 4.7% | No plan | SEC |
| Mar 13, 2023 | Mar 14, 2023 | CERS | President and CEO | Form 4 sale | 60,480 | $169k | 2.2% | Plan not stated | SEC |
| Mar 14, 2022 | Mar 15, 2022 | CERS | President and CEO | Form 4 sale | 165,021 | $832k | 7.7% | Plan not stated | SEC |
| Feb 25, 2022 | Mar 1, 2022 | CERS | President and CEO | Form 4 sale | 308,263 | $1.8M | 16.2% | Plan not stated | SEC |
| Mar 15, 2021 | Mar 16, 2021 | CERS | President and CEO | Form 4 sale | 156,407 | $998k | 12.4% | Plan not stated | SEC |
| Mar 17, 2020 | Mar 24, 2020 | CERS | President and CEO | Form 4 sale | 108,011 | $388k | 11.6% | Plan not stated | SEC |
| Mar 13, 2019 | Mar 13, 2019 | CERS | President and CEO | Form 4 sale | 45,459 | $273k | 7.0% | Plan not stated | SEC |
| Mar 13, 2018 | Mar 13, 2018 | CERS | President and CEO | Form 4 sale | 17,766 | $88k | 4.8% | Plan not stated | SEC |
| Mar 15, 2017 | Mar 15, 2017 | CERS | President and CEO | Form 4 sale | 8,786 | $37k | 2.7% | Plan not stated | SEC |
| Nov 30, 2015 | Dec 2, 2015 | CHINOOK THERAPEUTICS, INC. | Director | Form 4 sale | 3,000 | $92k | 100.0% | Unusual | SEC |